サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555526

性器ヘルペス市場：タイプ別、投与経路別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Genital Herpes Market, By Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 398 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
性器ヘルペス市場：タイプ別、投与経路別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月20日
発行: AnalystView Market Insights
ページ情報: 英文 398 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

性器ヘルペス市場規模は、2023年に9億8,767万米ドルとなり、2024年から2032年にかけてCAGR4.89%で拡大

性器ヘルペス市場 - 市場力学

性器ヘルペスの有病率の増加が市場の成長を促進すると予測

性器ヘルペスは、世界中で最も流行している性感染症（STI）にランクされています。この疾患の罹患率の増加は、診断サービスの需要と効果的な代替治療の必要性の両方に影響を与え、市場に様々な影響を及ぼします。世界保健機関（WHO）によると、世界で50歳未満の約37億人（67％）が単純ヘルペスウイルス1型（HSV-1）に感染しており、このウイルスは主に口唇ヘルペスを引き起こします。さらに、性器ヘルペスの主要な原因である単純ヘルペスウイルス2型（HSV-2）に感染している15歳から49歳の人口は、世界で推定4億9,100万人（13%）に上ります。さらに、単純ヘルペスウイルスに対するワクチンの研究が進められており、市場成長の大きな機会となっています。とはいえ、治療費の高さが市場拡大の課題となる可能性もあります。

性器ヘルペス市場 - 主要な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約4.89%のCAGRで毎年成長すると推定されます。

投与経路のセグメンテーションに基づくと、経口は2023年に最大市場シェアを示すと予測されました。

エンドユーザー別では、2023年に小売薬局が主要なタイプでした。

地域別では、北米が2023年に主要な収益源となりました。

性器ヘルペス市場 - セグメンテーション分析：

世界の性器ヘルペス市場は、タイプ、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって2つのセグメントに分類されます：診断と治療です。継続的な調査と意識の高まりにより、診断と治療の両市場は成長し、患者とヘルスケア専門家に改善されたソリューションを提供すると予測されます。

市場は投与経路によって3つのセグメントに分類されます：経口、注射剤、局所です。経口薬は全身的な有効性と使用の利便性により市場をリードしており、局所治療は標的を絞った緩和を提供します。注射剤は、あまり普及していないものの、重篤な症状を管理する上で重要な役割を果たしています。

市場はエンドユーザー別に、病院薬局、小売薬局、オンライン薬局、その他の2つの主要カテゴリーに分類されます。小売薬局は市場内で支配的な地位を占めています。小売薬局は、処方薬と市販薬の両方の治療へのアクセスを提供し、患者教育を促進し、ヘルスケア提供を強化することにより、性器ヘルペス分野で重要な役割を果たしています。

性器ヘルペス市場 - 地理的洞察

性器ヘルペス市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む広範な地域にまたがっています。これらの地域は、事業活動に貢献している国に基づいてさらに分類されます。北米は、主に同性愛者の間で性器ヘルペス治療に対する需要が高まっていることが市場成長の牽引役となっています。この地域は性器ヘルペスの有病率が高く、人口のかなりの部分がHSV-1およびHSV-2に罹患しています。この高い有病率は、徹底した診断と治療オプションの必要性を強調しています。米国食品医薬品局（FDA）は、マーケットプレースで有効かつ安全な薬剤を利用できるようにするため、新しい治療法の承認と規制において重要な役割を果たしています。米国国立医学図書館によると、米国では新生児1,000人に1人が新生児ヘルペス感染症と診断されており、母親が妊娠中に性器HSV感染症に罹患し、胎児に感染した場合、そのリスクは高まります。欧州は、性器ヘルペスの高い有病率と認知度に起因して、市場成長のための2番目に大きい地域としてランクされています。

性器ヘルペス市場 - 競合情勢：

性器ヘルペス市場は、診断テストや治療オプションの開発、生産、流通に従事する多数の参入企業によって特徴づけられる競合環境を示しています。メーカー各社は、より正確で迅速な診断検査の開発を目的とした投資を優先しています。さらに、製品へのアクセス性を高めるため、新たな市場や地域への進出を拡大しています。製薬会社、診断検査メーカー、小売薬局はそれぞれ、性器ヘルペスの治療と診断の提供に大きく貢献しています。

目次

第1章 性器ヘルペス市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 性器ヘルペスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 性器ヘルペスの業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 性器ヘルペス市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 性器ヘルペスの市場情勢

  • 性器ヘルペス市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 性器ヘルペス市場：タイプ別

  • 概要
    • セグメントシェア分析：タイプ別
    • 診断
    • 治療
      • アシクロビル
      • ファムシクロビル
      • バラシクロビル
      • その他

第8章 性器ヘルペス市場：投与経路別

  • 概要
    • セグメントシェア分析：投与経路別
    • 経口
    • 注射剤
    • 局所

第9章 性器ヘルペス市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第10章 性器ヘルペス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 性器ヘルペス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Abbott Laboratories
    • Sun Pharmaceuticals Industries Ltd.
    • Mylan N.V.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Dr. Reddy's Laboratories, ltd.
    • Novartis AG
    • Valeant Pharmaceuticals International Inc. etc.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV3635

REPORT HIGHLIGHT

Genital Herpes Market size was valued at USD 987.67 Million in 2023, expanding at a CAGR of 4.89% from 2024 to 2032.

Genital herpes is a prevalent sexually transmitted infection (STI) resulting from the herpes simplex virus (HSV). This condition is marked by recurring episodes of painful sores and blisters in the genital and anal regions. The two types of herpes simplex virus responsible for genital herpes are HSV-1 and HSV-2. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 were infected with HSV-1 in 2016. Additionally, around 491 million people aged 15 to 49 were reported to have an HSV-2 infection in the same year.

Genital Herpes Market- Market Dynamics

The increasing prevalence of genital herpes is projected to drive the growth of the market

Genital herpes ranks among the most prevalent sexually transmitted infections (STIs) across the globe. The increasing incidence of this condition carries various implications for the market, affecting both the demand for diagnostic services and the necessity for effective treatment alternatives. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 (67%) worldwide are infected with herpes simplex virus type 1 (HSV-1), which primarily causes oral herpes. Additionally, an estimated 491 million people aged 15 to 49 (13%) globally are affected by herpes simplex virus type 2 (HSV-2), the primary cause of genital herpes. Moreover, ongoing investigations into vaccines for the herpes simplex virus offer a considerable opportunity for market growth. Nevertheless, the high cost of treatment may pose a challenge to the expansion of the market.

Genital Herpes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.89% over the forecast period (2024-2032)

Based on the Route of administration segmentation, Oral was predicted to show maximum market share in the year 2023

Based on End-User segmentation, Retail Pharmacies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Genital Herpes Market- Segmentation Analysis:

The Global Genital Herpes Market is segmented based on Type, Route of Administration, End-User, and Region.

The market is classified into two segments according to Type: Diagnosis and Treatment. With ongoing research and heightened awareness, the market for both diagnosis and treatment is anticipated to grow, providing improved solutions for patients and healthcare professionals.

The market is classified into three segments according to the Route of Administration: Oral, Injectable, and Topical. Oral medications lead the market owing to their systemic effectiveness and convenience of use, whereas topical treatments offer targeted relief. Injectable medications, although less prevalent, play a crucial role in managing severe conditions.

The market is segmented into two primary categories according to End-User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. Retail Pharmacies hold a dominant position within the market. They play an essential role in the genital herpes sector by providing access to both prescription and over-the-counter treatments, facilitating patient education, and enhancing healthcare delivery.

Genital Herpes Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America leads in market growth, primarily driven by the rising demand for genital herpes treatments among homosexual individuals. The region exhibits a significant prevalence of genital herpes, with a considerable segment of the population affected by HSV-1 and HSV-2. This elevated prevalence underscores the need for thorough diagnostic and treatment options. The U.S. Food and Drug Administration (FDA) is instrumental in the approval and regulation of new therapies, ensuring the availability of effective and safe medications in the marketplace. According to the National Library of Medicine, 1 in 1,000 newborns in the United States is diagnosed with neonatal herpes infection, with the risk increasing if the mother contracts genital HSV infection during pregnancy and transmits it to the fetus. Europe ranks as the second-largest region for market growth, attributed to the high prevalence and awareness of genital herpes.

Genital Herpes Market- Competitive Landscape:

The genital herpes market exhibits a competitive environment, characterized by numerous participants engaged in the development, production, and distribution of diagnostic tests and therapeutic options. Manufacturers are prioritizing investments aimed at creating more precise and rapid diagnostic tests. Additionally, they are broadening their reach into new markets and regions to enhance product accessibility. Pharmaceutical firms, diagnostic test manufacturers, and retail pharmacies each contribute significantly to the provision of treatments and diagnostics for genital herpes.

Recent Developments:

In November 2023, Abbott Laboratories obtained approval from the U.S. Food and Drug Administration for its molecular human papillomavirus (HPV) screening test, thereby enhancing the company's portfolio of cancer screening instruments. This latest addition to the Alinity M series of diagnostic assays is suitable for screening by existing guidelines, as well as for diagnostic purposes, and offers comprehensive insights into the genotypes of the virus that may lead to cancer.

In March 2024, Sun Pharmaceutical Industries Inc. announced the recall of 47,520 bottles of the 40 mg medication and 7,488 bottles of the 80 mg formulation, citing deviations from Current Good Manufacturing Practice (CGMP) regulations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENITAL HERPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Sun Pharmaceuticals Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories, ltd.
  • Novartis AG
  • Valeant Pharmaceuticals International Inc. etc.
  • Others

GLOBAL GENITAL HERPES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diagnosis
  • Treatment
  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others

GLOBAL GENITAL HERPES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable
  • Topical

GLOBAL GENITAL HERPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

GLOBAL GENITAL HERPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genital Herpes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genital Herpes Market Snippet by Type
    • 2.1.2. Genital Herpes Market Snippet by Route of Administration
    • 2.1.3. Genital Herpes Market Snippet by End-User
    • 2.1.4. Genital Herpes Market Snippet by Country
    • 2.1.5. Genital Herpes Market Snippet by Region
  • 2.2. Competitive Insights

3. Genital Herpes Key Market Trends

  • 3.1. Genital Herpes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genital Herpes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genital Herpes Market Opportunities
  • 3.4. Genital Herpes Market Future Trends

4. Genital Herpes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genital Herpes Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genital Herpes Market Landscape

  • 6.1. Genital Herpes Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genital Herpes Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Diagnosis
    • 7.1.3. Treatment
      • 7.1.3.1. Acyclovir
      • 7.1.3.2. Famciclovir
      • 7.1.3.3. Valacyclovir
      • 7.1.3.4. Others

8. Genital Herpes Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable
    • 8.1.4. Topical

9. Genital Herpes Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Others

10. Genital Herpes Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Genital Herpes Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Genital Herpes Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Genital Herpes Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Genital Herpes Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Genital Herpes Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Genital Herpes Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Teva Pharmaceutical Industries Ltd.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Sun Pharmaceuticals Industries Ltd.
    • 11.2.4. Mylan N.V.
    • 11.2.5. Pfizer Inc.
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Dr. Reddy's Laboratories, ltd.
    • 11.2.8. Novartis AG
    • 11.2.9. Valeant Pharmaceuticals International Inc. etc.
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us